Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from ConvaTec ( (GB:CTEC) ).
ConvaTec Group PLC has executed a share buyback, purchasing over 2 million ordinary shares as part of its $300 million buyback program announced earlier in August 2025. This strategic move is aimed at consolidating the company’s share capital, potentially enhancing shareholder value and reflecting confidence in its financial health.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £273.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score is driven primarily by its strong financial performance, characterized by consistent revenue growth and solid profitability. Technical analysis indicates a moderate upward trend, although valuation metrics suggest the stock may be overvalued. The absence of earnings call insights and corporate events limits additional context.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the healthcare industry, focusing on medical products and technologies. The company specializes in wound care, ostomy care, continence and critical care, and infusion devices, serving a global market.
Average Trading Volume: 7,400,390
Technical Sentiment Signal: Strong Buy
Current Market Cap: £4.84B
For detailed information about CTEC stock, go to TipRanks’ Stock Analysis page.